课题基金 / 基金详情

项目摘要

项目成果

JAMES M BINLEY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): During HIV-1 infection, the envelope protein (Env) is presented to the immune system in many forms. In the currently accepted model, the functional form of Env is a trimeric complex of gp120/gp41 heterodimers. Examples of non-functional forms of Env include monomeric gp120, uncleaved gp160 precursor and gp41 from which gp120 has dissociated. The functional trimer has evolved to be a compact structure; indeed, while most monoclonal antibodies (mAbs) recognize only non-functional forms of Env, neutralizing mAbs appear to also bind the functional Env trimer. Env fragments released from particles and infected cells have been considered responsible for the generally poor quality neutralizing response to HIV-1 infection. However, new evidence suggests that infectious HIV-1 particles also bear non-functional forms of Env. In pursuing the goal of developing an HIV-1 vaccine able to elicit potent neutralizing antibodies, we have chosen HIV-1 pseudovirions as model immunogens. In Specific Aim 1, we will use a comprehensive set of techniques in an attempt to generate pseudovirions that exclusively bear functional trimers that are only recognized by neutralizing mAbs. Given the compact, antibody-resistant nature of the trimeric complex, we will expand our studies in Specific Aim 2 to include the receptor-engaged form of Env as an alternative neutralization target. Env-receptor binding induces exposure of otherwise cryptic structures. Although these structures are only transiently exposed in natural infection, they are plausible neutralization targets recognized by well-characterized neutralizing mAbs, exemplified by 2F5. To this end, we have generated a pseudovirion mutant that attaches to susceptible cells but only fuses in a redox-dependent manner. Using this model, we will investigate post-attachment neutralization in HIV-I+ serum. In Specific Aim 3, we will test the immunogenicity of i) pseudovirions bearing only functional trimers and ii) receptor-engaged pseudovirions attached to autologous macaque lymphocytes.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
Topological analysis of HIV-1 glycoproteins expressed in situ on virus surfaces reveals tighter packing but greater conformational flexibility than for soluble gp120.
对病毒表面原位表达的 HIV-1 糖蛋白的拓扑分析表明,与可溶性 gp120 相比,其包装更紧密,但构象灵活性更大。
DOI: 10.1128/jvi.01145-13
发表时间: 2013
期刊: Journal of virology
影响因子: 5.4
作者: [Tong,Tommy, Osawa,Keiko, Robinson,JamesE, Crooks,EmaT, Binley,JamesM]
通讯作者: Binley,JamesM
DOI: 10.1371/journal.ppat.1004932
发表时间: 2015-05
期刊: PLoS pathogens
影响因子: 6.7
作者: [Crooks ET, Tong T, Chakrabarti B, Narayan K, Georgiev IS, Menis S, Huang X, Kulp D, Osawa K, Muranaka J, Stewart-Jones G, Destefano J, O'Dell S, LaBranche C, Robinson JE, Montefiori DC, McKee K, Du SX, Doria-Rose N, Kwong PD, Mascola JR, Zhu P, Schief WR, Wyatt RT, Whalen RG, Binley JM]
通讯作者: Binley JM
DOI: 10.1371/journal.pone.0072054
发表时间: 2013
期刊: PloS one
影响因子: 3.7
作者: [Gach JS, Quendler H, Tong T, Narayan KM, Du SX, Whalen RG, Binley JM, Forthal DN, Poignard P, Zwick MB]
通讯作者: Zwick MB
Rescue of broadly neutralizing mAbs using native trimer
Pure and Authentic HIV-1 Env Immunogens
Rescue of broadly neutralizing mAbs using native trimer
Rescue of broadly neutralizing mAbs using native trimer
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究